A comparison of ease of i-gel insertion using injection Dexmedetomidine-Propofol intravenously versus injection Fentanyl-Propofol intravenously.

A comparative evaluation of i-gel insertion conditions using injection Dexmedetomidine-Propofol IV versus injection Fentanyl-Propofol IV .A prospective,randomized,double blinded study. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/01/061400

Enrollment

110

Registered

2024-01-12

Start date

Unknown

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Injection Dexmedetomidine: Injection Dexmedetomidine IV at 1mcg/kg over 10mins followed by .5mcg/kg Control Intervention1: Injection Fentanyl: Injection Fentanyl intravenously 1.5mcg/kg

Eligibility

Inclusion criteria

Inclusion criteria: Patient informed consent. Patient undergoing minor elective surgeries. Asa grade i to ii. Modified mallampatti score i and ii. Mouth opening =3 fingers.

Exclusion criteria

Exclusion criteria: Patient refusal A history of allergy to study drugs. Reduced mouth opening Upper/lower airway obstruction. On beta blockers or bradycardia( Patients with risk of aspiration such as full stomach,pregnanacy,hiatus hernia.

Design outcomes

Primary

Measure	Time frame
To compare the success rate of i-gel insertion with injection propofol IV induction after pre-treatment with injection dexmedetomidine IV or injection fentanyl IV in patients with MPS I and MPS II. Timepoint: At the time if i-gel insertion	—

Secondary

Measure	Time frame
To assess ease of i-gel insertion . To assess hemodynamic changes . Timepoint: at 0,1,3,5 mins and every 5mins thereafter for 30mins	—

Countries

India

Contacts

Public ContactAnanya Nair

Tata motors hospital

swastikac@tatamotors.com9234500611

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026